4. Respiratory Failure (RF)
Definitions
Clinical conditions in
which PaO2 < 60 mmHg
while breathing room air
or a PaCO2 > 50 mmHg
Failure of oxygenation
and carbon dioxide
elimination
Acute and chronic
Type 1 or 2
5. Classification of RF
Type 1
Hypoxemic RF **
PaO2 < 60 mmHg with
normal or ↓ PaCO2
Associated with acute
diseases of the lung
Pulmonary edema
(Cardiogenic,
noncardiogenic (ARDS),
pneumonia, pulmonary
hemorrhage, and collapse
Type 2
Hypercapnic RF
PaCO2 > 50 mmHg
Hypoxemia is common
Drug overdose,
neuromuscular disease,
chest wall deformity,
COPD, and Bronchial
asthma
6. Distinction between Acute and Chronic RF
Acute RF
Develops over minutes to
hours
↓ pH quickly to <7.2
Example; Pneumonia
Chronic RF
Develops over days
↑ in HCO3
↓ pH slightly
Polycythemia, Corpulmonale
Example; COPD
8. Pathophysiologic causes of Acute RF
1 - Hypoventilation
Occurs when ventilation ↓
4-6 l/min
Causes
Depression of CNS
from drugs
Neuromuscular disease
of respiratory ms
↑PaCO2 and ↓PaO2
Alveolar –arterial PO2
gradient is normal
COPD
10. Pathophysiologic causes of Acute RF
2 -V/Q mismatch
Most common cause of
hypoxemia
Low V/Q ratio, may occur
either from
Decrease of ventilation 2ry
to airway or interstitial lung
disease
Overperfusion in the
presence of normal
ventilation e.g. PE
Admin. of 100% O2 eliminate
hypoxemia
12. Pathophysiologic causes of Acute RF
3 -Shunt
The deoxygenated blood
bypasses the ventilated
alveoli and mixes with
oxygenated blood →
hypoxemia
Persistent of hypoxemia
despite 100% O2 inhalation
Hypercapnia occur when
shunt is excessive > 60%
13. Pathophysiologic causes of Acute RF
3 – Causes of Shunt
Intracardiac
Right to left shunt
Fallot’s tetralogy
Eisenmenger’s
syndrome
Pulmonary
A/V malformation
Pneumonia
Pulmonary edema
Atelectasis/collapse
Pulmonary Hge
Pulmonary contusion
15. Pathophysiologic causes of Acute RF
4 - Diffusion abnormality
Less common
Due to
abnormality of the
alveolar membrane
↓ the number of the
alveoli
Causes
ARDS
Fibrotic lung disease
16. Diagnosis of RF
1 – Clinical (symptoms, signs)
Hypoxemia
Dyspnea, Cyanosis
Confusion, somnolence, fits
Tachycardia, arrhythmia
Tachypnea (good sign)
Use of accessory ms
Nasal flaring
Recession of intercostal ms
Polycythemia
Pulmonary HTN,
Corpulmonale, Rt. HF
Hypercapnia
↑Cerebral blood flow, and
CSF Pressure
Headache
Asterixis
Papilloedema
Warm extremities,
collapsing pulse
Acidosis (respiratory, and
metabolic)
↓pH, ↑ lactic acid
17. Diagnosis of RF
2 – Causes
1 – CNS
Depression of the neural
drive to breath
Brain stem tumors or vascular
abnormality
Overdose of a narcotic, sedative
Myxedema, chronic metabolic
alkalosis
Acute or chronic hypoventilation
and hypercapnia
18. Diagnosis of RF
2 – Causes
2 - Disorders of peripheral
nervous system, Respiratory
ms, and Chest wall
Inability to maintain a level
of minute ventilation
appropriate for the rate of
CO2 production
Guillian-Barre syndrome,
muscular dystrophy,
myasthenia gravis, KS,
morbid obesity
Hypoxemia and hypercapnia
19. Diagnosis of RF
2 – Causes
3 - Abnormities of the
airways
Upper airways
Acute epiglotitis
Tracheal tumors
Lower airway
COPD, Asthma, cystic
fibrosis
Acute and chronic
hypercapnia
20. Diagnosis of RF
2 – Causes
4 - Abnormities of the
alveoli
Diffuse alveolar filling
hypoxemic RF
Cardiogenic and
noncardiogenic
pulmonary edema
Aspiration pneumonia
Pulmonary hemorrhage
Associate with
Intrapulmonary shunt and
increase work of breathing
21. Diagnosis of RF
3 – Common causes
Hypoxemic RF
Chronic bronchitis, emphysema
Pneumonia, pulmonary edema
Pulmonary fibrosis
Asthma, pneumothorax
Pulmonary embolism,
Pulmonary hypertension
Bronchiectasis, ARDS
Fat embolism, KS, Obesity
Cyanotic congenital heart disease
Granulomatous lung disease
Hypercapnic RF
Chronic bronchitis,emphysema
Severe asthma, drug overdose
Poisonings, Myasthenia gravis
Polyneuropathy, Poliomyelitis
Primary ms disorders
1ry alveolar hypoventilation
Obesity hypoventilation synd.
Pulmonary edema, ARDS
Myxedema, head and cervical
cord injury
24. Diagnosis of RF
3 - Investigations
ECG → cardiac cause of RF
→ Arrhythmia due to hypoxemia and
severe acidosis
■ Right heart catheterization to measure
●Pulmonary capillary wedge pressure (PCWP)
● Normal → ARDS (<18 mmHg)
● Increased → Cardiogenic pulmonary
edema
26. Distinction between Noncardiogenic (ARDS) and
Cardiogenic pulmonary edema
ARDS
Tachypnea, dyspnea,
crackles
Aspiration, sepsis
3 to 4 quadrant of alveolar
flooding with normal heart
size, systolic, diastolic
function
Decreased compliance
Severe hypoxemia
refractory to O2 therapy
PCWP is normal <18 mm
Hg
Cardiogenic edema
Tachypnea, dyspnea,
crackles
Lt ventricular dysfunction,
valvular disease, IHD
Cardiomegaly, vascular
redistribution, pleural
effusion, perihilar bat-
wing distribution of
infiltrate
Hypoxemia improved on
high flow O2
PCWP is High >18 mmHg
28. Management of ARF
ICU admition
1 -Airway management
Endotracheal intubation:
Indications
Severe Hypoxemia
Altered mental status
Importance
precise O2 delivery to the lungs
remove secretion
ensures adequate ventilation
29. Management of ARF
2 -Correction of hypoxemia
O2 administration via
nasal prongs, face mask,
intubation and Mechanical
ventilation
Goal: Adequate O2
delivery to tissues
PaO2 = > 60 mmHg
Arterial O2 saturation
>90%
30. Management of ARF
3- Correction of hypercapnia
Control the underlying cause
Controlled O2 supply
1 -3 lit/min, titrate according
O2 saturation
O2 supply to keep the O2
saturation >90% but <93 to
avoid inducing hypercapnia
COPD-chronic bronchitis,
emphysema
32. Management of ARF
4 – Mechanical
ventilation
Indications
Persistence hypoxemia
despite O2supply
Decreased level of
consciousness
Hypercapnia with severe
acidosis (pH< 7.2)
33. Management of ARF
4 - Mechanical ventilation
Increase PaO2
Lower PaCO2
Rest respiratory ms
(respiratory ms fatigue)
Ventilator
Assists or controls the
patient breathing
The lowest FIO2 that
produces SaO2 >90% and
PO2 >60 mmHg should be
given to avoid O2 toxicity
34. Management of ARF
5 -PEEP (positive End-
Expiratory pressure
Used with mechanical ventilation
Increase intrathoracic pressure
Keeps the alveoli open
Decrease shunting
Improve gas exchange
Hypoxemic RF (type 1)
ARDS
Pneumonias
35. Management of ARF
6 - Noninvasive
Ventilatory support
(IPPV)
Mild to moderate RF
Patient should have
Intact airway,
Alert, normal airway
protective reflexes
Nasal or full face mask
Improve oxygenation,
Reduce work of
breathing
Increase cardiac output
AECOPD, asthma, CHF
36. Management of ARF
7 - Treatment of the
underlying causes
After correction of hypoxemia,
hemodynamic stability
Antibiotics
Pneumonia
Infection
Bronchodilators (COPD, BA)
Salbutamol
reduce bronchospasm
airway resistance
37. 7 - Treatment of the
underlying causes
Anticholinergics (COPD,BA)
Ibratropium bromide
inhibit vagal tone
relax smooth ms
Theophylline (COPD, BA)
improve diaphragmatic
contraction
relax smooth ms
Diuretics (pulmonary edema)
Frusemide, Metalzone
Management of ARF
38. Management of ARF
7 - Treatment of the
underlying causes
Methyl prednisone (COPD,
BA, acute esinophilic pn)
Reverse bronchospasm,
inflammation
Fluids and electrolytes
Maintain fluid balance and
avoid fluid overload
IV nutritional support
To restore strength, loss of
ms mass
Fat, carbohydrate, protein
39. Management of ARF
7 - Treatment of the
underlying causes
Physiotherapy
Chest percussion to
loosen secretion
Suction of airways
Help to drain secretion
Maintain alveolar
inflation
Prevent atelectasis, help
lung expansion
40. Management of ARF
8 - Weaning from mechanical ventilation
Stable underlying respiratory status
Adequate oxygenation
Intact respiratory drive
Stable cardiovascular status
Patient is a wake, has good nutrition, able to cough and
breath deeply
42. Prognosis of ARF
Mortality rate for ARDS → 40%
Younger patient <60 has better survival rate
75% of patient survive ARDS have impairment of
pulmonary function one or more years after recovery
Mortality rate for COPD →10%
Mortality rate increase in the presence of hepatic,
cardiovascular, renal, and neurological disease